400-920-2911 sales@csnpharm.cn
CAS No.: 877877-35-5
TW-37 is a nonpeptide inhibitor to recombinant Bcl-2, Bcl-xL and Mcl-1 with Ki of 0.29 μM, 1.11 μM and 0.26 μM, respectively.
生物活性
实验方案
技术信息
CAS号 | 877877-35-5 | 储存条件 |
|
|
分子式 | C33H35NO6S | 运输 | 蓝冰 | |
分子量 | 573.70 | 别名 |
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
human A204 cell | - | Growth inhibition assay | - | Inhibition of human A204 cell growth in a cell viability assay, IC50=97.84 nM | SANGER |
human A2780 cell | - | Growth inhibition assay | - | Inhibition of human A2780 cell growth in a cell viability assay, IC50=0.21846 μM | SANGER |
human A375 cell | - | Growth inhibition assay | - | Inhibition of human A375 cell growth in a cell viability assay, IC50=88.83 nM | SANGER |
human A427 cell | - | Growth inhibition assay | - | Inhibition of human A427 cell growth in a cell viability assay, IC50=44.69 nM | SANGER |
human A549 cell | - | Growth inhibition assay | - | Inhibition of human A549 cell growth in a cell viability assay, IC50=14.09 nM | SANGER |
human A673 cell | - | Growth inhibition assay | - | Inhibition of human A673 cell growth in a cell viability assay, IC50=53.85 nM | SANGER |
human AGS cell | - | Growth inhibition assay | - | Inhibition of human AGS cell growth in a cell viability assay, IC50=37.53 nM | SANGER |
human BHT-101 cell | - | Growth inhibition assay | - | Inhibition of human BHT-101 cell growth in a cell viability assay, IC50=21.83 nM | SANGER |
human Ca9-22 cell | - | Growth inhibition assay | - | Inhibition of human Ca9-22 cell growth in a cell viability assay, IC50=3.82 nM | SANGER |
human CHL-1 cell | - | Growth inhibition assay | - | Inhibition of human CHL-1 cell growth in a cell viability assay, IC50=11.9 nM | SANGER |
human CP50-MEL-B cell | - | Growth inhibition assay | - | Inhibition of human CP50-MEL-B cell growth in a cell viability assay, IC50=69.59 nM | SANGER |
human Daoy cell | - | Growth inhibition assay | - | Inhibition of human Daoy cell growth in a cell viability assay, IC50=0.14073 μM | SANGER |
human DU-145 cell | - | Growth inhibition assay | - | Inhibition of human DU-145 cell growth in a cell viability assay, IC50=52.13 nM | SANGER |
human GB-1 cell | - | Growth inhibition assay | - | Inhibition of human GB-1 cell growth in a cell viability assay, IC50=98.69 nM | SANGER |
human GCIY cell | - | Growth inhibition assay | - | Inhibition of human GCIY cell growth in a cell viability assay, IC50=20.83 nM | SANGER |
human HCT-116 cell | - | Growth inhibition assay | - | Inhibition of human HCT-116 cell growth in a cell viability assay, IC50=52.66 nM | SANGER |
human HEC-1 cell | - | Growth inhibition assay | - | Inhibition of human HEC-1 cell growth in a cell viability assay, IC50=81.37 nM | SANGER |
human HOS cell | - | Growth inhibition assay | - | Inhibition of human HOS cell growth in a cell viability assay, IC50=84.71 nM | SANGER |
human Hs-578-T cell | - | Growth inhibition assay | - | Inhibition of human Hs-578-T cell growth in a cell viability assay, IC50=23.59 nM | SANGER |
human HT-144 cell | - | Growth inhibition assay | - | Inhibition of human HT-144 cell growth in a cell viability assay, IC50=0.15201 μM | SANGER |
human HuH-7 cell | - | Growth inhibition assay | - | Inhibition of human HuH-7 cell growth in a cell viability assay, IC50=32.82 nM | SANGER |
human HUTU-80 cell | - | Growth inhibition assay | - | Inhibition of human HUTU-80 cell growth in a cell viability assay, IC50=87.01 nM | SANGER |
human JAR cell | - | Growth inhibition assay | - | Inhibition of human JAR cell growth in a cell viability assay, IC50=2.6 nM | SANGER |
human LoVo cell | - | Growth inhibition assay | - | Inhibition of human LoVo cell growth in a cell viability assay, IC50=0.16093 μM | SANGER |
human LXF-289 cell | - | Growth inhibition assay | - | Inhibition of human LXF-289 cell growth in a cell viability assay, IC50=72.85 nM | SANGER |
human MC-IXC cell | - | Growth inhibition assay | - | Inhibition of human MC-IXC cell growth in a cell viability assay, IC50=75.33 nM | SANGER |
human MDA-MB-231 cell | - | Growth inhibition assay | - | Inhibition of human MDA-MB-231 cell growth in a cell viability assay, IC50=0.10807 μM | SANGER |
human MDA-MB-361 cell | - | Growth inhibition assay | - | Inhibition of human MDA-MB-361 cell growth in a cell viability assay, IC50=0.2264 μM | SANGER |
human MDA-MB-453 cell | - | Growth inhibition assay | - | Inhibition of human MDA-MB-453 cell growth in a cell viability assay, IC50=0.15188 μM | SANGER |
human MG-63 cell | - | Growth inhibition assay | - | Inhibition of human MG-63 cell growth in a cell viability assay, IC50=0.11248 μM | SANGER |
human NB14 cell | - | Growth inhibition assay | - | Inhibition of human NB14 cell growth in a cell viability assay, IC50=76.45 nM | SANGER |
human NB7 cell | - | Growth inhibition assay | - | Inhibition of human NB7 cell growth in a cell viability assay, IC50=29.28 nM | SANGER |
human NCI-H1581 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H1581 cell growth in a cell viability assay, IC50=67.64 nM | SANGER |
human NY cell | - | Growth inhibition assay | - | Inhibition of human NY cell growth in a cell viability assay, IC50=0.17762 μM | SANGER |
human RKO cell | - | Growth inhibition assay | - | Inhibition of human RKO cell growth in a cell viability assay, IC50=15.17 nM | SANGER |
human RPMI-2650 cell | - | Growth inhibition assay | - | Inhibition of human RPMI-2650 cell growth in a cell viability assay, IC50=0.23831 μM | SANGER |
human SAS cell | - | Growth inhibition assay | - | Inhibition of human SAS cell growth in a cell viability assay, IC50=33.18 nM | SANGER |
human SF126 cell | - | Growth inhibition assay | - | Inhibition of human SF126 cell growth in a cell viability assay, IC50=57.07 nM | SANGER |
human SK-MEL-30 cell | - | Growth inhibition assay | - | Inhibition of human SK-MEL-30 cell growth in a cell viability assay, IC50=37.97 nM | SANGER |
human SK-MEL-5 cell | - | Growth inhibition assay | - | Inhibition of human SK-MEL-5 cell growth in a cell viability assay, IC50=69.25 nM | SANGER |
human SK-UT-1 cell | - | Growth inhibition assay | - | Inhibition of human SK-UT-1 cell growth in a cell viability assay, IC50=28.68 nM | SANGER |
human SW1783 cell | - | Growth inhibition assay | - | Inhibition of human SW1783 cell growth in a cell viability assay, IC50=0.21301 μM | SANGER |
human SW756 cell | - | Growth inhibition assay | - | Inhibition of human SW756 cell growth in a cell viability assay, IC50=0.11236 μM | SANGER |
human SW872 cell | - | Growth inhibition assay | - | Inhibition of human SW872 cell growth in a cell viability assay, IC50=58.9 nM | SANGER |
human SW982 cell | - | Growth inhibition assay | - | Inhibition of human SW982 cell growth in a cell viability assay, IC50=0.1107 μM | SANGER |
human U-87-MG cell | - | Growth inhibition assay | - | Inhibition of human U-87-MG cell growth in a cell viability assay, IC50=82.24 nM | SANGER |
human UACC-62 cell | - | Growth inhibition assay | - | Inhibition of human UACC-62 cell growth in a cell viability assay, IC50=34.35 nM | SANGER |
human YH-13 cell | - | Growth inhibition assay | - | Inhibition of human YH-13 cell growth in a cell viability assay, IC50=70.59 nM | SANGER |
human YKG-1 cell | - | Growth inhibition assay | - | Inhibition of human YKG-1 cell growth in a cell viability assay, IC50=29.76 nM | SANGER |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网